A hydrochloride salt of Doxorubicin, which is a chemotherapy drug. It is a a 14-hydroxylated version of daunorubicin. It helps in the treament of leukemia nad cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma.. Reference standards of Doxorubicin Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Doxorubicin Hydrochloride
Catalogue No.:PA 04 45000
CAS :
Molecular Formula : C27H30ClNO11
Molecular Weight : 579.98
(8S,10S)-10[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Catalogue No.:PA 04 45020
Molecular Formula : C29H34BrNO11
Molecular Weight : 652.48
(8S,10S)-10[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrobromide
Catalogue No.:PA 04 45021
Molecular Formula : C29H35Br2NO11
Molecular Weight : 733.4
(8S,10S)-10[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Catalogue No.:PA 04 45030
Molecular Formula : C27H28BrNO10
Molecular Weight : 606.42
(8S,10S)-10[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrobromide
Catalogue No.:PA 04 45031
Molecular Formula : C27H29Br2NO10
Molecular Weight : 687.33
Doxorubicinone
Catalogue No.:PA 04 45040
Molecular Formula : C21H18O9
Molecular Weight : 414.36
14-Bromo 4’-epi-Daunorubicin Hydrochloride
Catalogue No.:PA 04 0450031
Molecular Formula : C27H29BrClNO10
Molecular Weight : 642.88
Esorubicin Hydrochloride
Catalogue No.:PA 04 0451002
Molecular Formula : C27H30ClNO10
Molecular Weight : 563.98
Daunosamine
Catalogue No.:PA 04 0451003
Molecular Formula : C6H13NO3
Molecular Weight : 147.17
L-Daunosamine
Catalogue No.:PA 04 0451004
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
